|
Market Closed -
Swiss Exchange
11:31:02 2026-11-09 am EST
|
5-day change | 1st Jan Change | ||
| 133.46 CHF | +0.29% |
|
+1.48% | +21.77% |
| Nov. 09 | US FDA approves Bayer's blood thinner to prevent repeat strokes | RE |
| Nov. 09 | European Stocks Close Higher in Monday Trading Amid Easing Bond Yields, Oil Prices | MT |
| Market Cap | 307B 274B 252B 229B 434B 28,765B 444B 3,015B 1,202B 15,400B 1,152B 1,127B 48,503B | P/E 2026 * |
23.8x | P/E 2027 * | 18.9x |
|---|---|---|---|---|---|
| Enterprise Value | 341B 304B 280B 254B 482B 31,959B 494B 3,350B 1,335B 17,110B 1,280B 1,252B 53,888B | EV / Sales 2026 * |
5.93x | EV / Sales 2027 * | 5.45x |
| Free-Float |
91.66% | Yield 2026 * |
2.69% | Yield 2027 * | 2.83% |
| Markets | Quality | ||
|---|---|---|---|
Swiss Exchange
| NOVN | Delayed | |
CBOE
| 0QLR | Real-time | |
|
Borsa Italiana
| 1NOVN | End-of-day quote | |
|
Tradegate
| NOT | Real-time | |
|
Xetra
| NOT | Delayed | |
|
Xetra
| NOT | End-of-day quote | |
|
Boerse Muenchen
| NOT | Real-time | |
|
Deutsche Boerse AG
| NOT | Delayed | |
|
Börse Stuttgart
| NOT | Delayed | |
|
London S.E.
| 0QLR | Delayed | |
|
OTC Markets
| NVSEF | Delayed | |
|
Deutsche Boerse AG
| NOT | End-of-day quote | |
|
CBOE
| Real-time | ||
|
Mexican S.E.
| NOVN N | End-of-day quote | |
|
CBOE
| 0QLR | Real-time | |
|
Wiener Boerse
| NOVN | End-of-day quote |
Last Transcript: Novartis AG
| 1 day | +0.29% | ||
| 1 week | +1.48% | ||
| Current month | -0.24% | ||
| 1 month | +12.06% | ||
| 3 months | +5.94% | ||
| 6 months | +17.73% | ||
| Current year | +21.77% |
| 1 week | 130.1 |  | 135.22 |
| 1 month | 118.58 | | 135.22 |
| Current year | 107.68 | | 135.22 |
| 1 year | 99.45 | | 135.22 |
| 3 years | 81.1 | | 135.22 |
| 5 years | 72.84 | | 135.22 |
| 10 years | 65.09 | | 135.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2018-01-31 | |
Mukul Mehta
DFI | Director of Finance/CFO | - | 2026-03-15 |
Karen Hale
CMP | Compliance Officer | 58 | 2025-04-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Nancy Andrews
BRD | Director/Board Member | 67 | 2014-12-31 |
| Director/Board Member | 69 | 2015-12-31 | |
Ton Büchner
BRD | Director/Board Member | 61 | 2015-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/18/26 | Sell | -5,200 | 0.0003% | |||
| 5/4/26 | Sell | 6,800 | 0.0003% | |||
| 2/17/26 | Sell | 30,743 | 0.0015% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.29% | +1.48% | +30.84% | +58.32% | 307B | |
| +4.28% | +0.07% | +52.75% | +138.78% | 1,206B | |
| +2.13% | +4.27% | +51.21% | +91.36% | 665B | |
| +0.68% | +1.54% | +33.83% | +112.47% | 515B | |
| +2.77% | +0.98% | +49.44% | +68.46% | 381B | |
| +1.38% | +0.27% | +72.42% | +45.30% | 362B | |
| +0.98% | +1.49% | +9.04% | +34.78% | 289B | |
| +1.04% | -0.05% | +45.29% | +76.18% | 249B | |
| +1.46% | -0.59% | +42.48% | +125.82% | 207B | |
| +1.24% | +0.96% | -6.32% | -60.78% | 177B | |
| Average | +1.66% | +0.45% | +38.10% | +69.07% | 436B | |
| Weighted average by Cap. | +2.25% | +0.67% | +43.87% | +89.67% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 57.51B 51.33B 47.23B 42.87B 81.24B 5,390B 83.26B 565B 225B 2,886B 216B 211B 9,089B | 61.44B 54.84B 50.47B 45.8B 86.8B 5,759B 88.96B 604B 241B 3,083B 231B 226B 9,711B |
| Net income | 13.3B 11.87B 10.92B 9.91B 18.79B 1,246B 19.25B 131B 52.07B 667B 49.91B 48.84B 2,102B | 15.98B 14.26B 13.13B 11.91B 22.58B 1,498B 23.14B 157B 62.58B 802B 59.98B 58.7B 2,526B |
| Net Debt | 34.07B 30.41B 27.99B 25.4B 48.14B 3,194B 49.33B 335B 133B 1,710B 128B 125B 5,385B | 28.15B 25.12B 23.12B 20.98B 39.76B 2,638B 40.75B 277B 110B 1,412B 106B 103B 4,449B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-09 | CHF 133.46 | +0.29% | 2,175,758 |
| 26-11-06 | CHF 133.08 | -0.78% | 4,011,966 |
| 26-11-05 | CHF 134.12 | -0.10% | 5,037,076 |
| 26-11-04 | CHF 134.26 | +2.10% | 3,843,495 |
| 26-11-03 | CHF 131.50 | -0.02% | 2,849,340 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- NOVN Stock
Select your edition
All financial news and data tailored to specific country editions
